{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,12]],"date-time":"2026-03-12T13:52:55Z","timestamp":1773323575474,"version":"3.50.1"},"reference-count":122,"publisher":"Scientific Research Publishing, Inc.","issue":"05","license":[{"start":{"date-parts":[[2012,1,1]],"date-time":"2012-01-01T00:00:00Z","timestamp":1325376000000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JCT"],"published-print":{"date-parts":[[2012]]},"DOI":"10.4236\/jct.2012.325089","type":"journal-article","created":{"date-parts":[[2012,11,2]],"date-time":"2012-11-02T05:36:34Z","timestamp":1351834594000},"page":"689-711","source":"Crossref","is-referenced-by-count":2,"title":["Synthesis of Gemcitabine-(C&amp;lt;sub&amp;gt;4&amp;lt;\/sub&amp;gt;-&amp;lt;i&amp;gt;amide&amp;lt;\/i&amp;gt;)-[anti-HER2\/&amp;lt;i&amp;gt;neu&amp;lt;\/i&amp;gt;] Utilizing a UV-Photoactivated Gemcitabine Intermediate: Cytotoxic Anti-Neoplastic Activity against Chemotherapeutic-Resistant Mammary Adenocarcinoma SKBr-3"],"prefix":"10.4236","volume":"03","author":[{"given":"Cody","family":"P. Coyne","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Toni","family":"Jones","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ryan","family":"Bear","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"2751","reference":[{"key":"ref","doi-asserted-by":"publisher","DOI":"10.1021\/bc00009a001"},{"key":"ref","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejps.2004.09.005"},{"key":"ref","doi-asserted-by":"publisher","DOI":"10.1021\/jm020276c"},{"key":"ref","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-06-2776"},{"key":"ref","doi-asserted-by":"publisher","DOI":"10.1016\/S0731-7085(03)00434-5"},{"key":"ref","doi-asserted-by":"crossref","unstructured":"R. S. Greenfield, T. Kaneko, A. Daues, M. A. Edson, K. A. Fitzgerald, L. J. Olech, J. A. Grattan, G. L. Spitalny and G. R. Braslawsky, \u201cEvaluation In-Vitro of Adriamycin Immunoconjugates Synthesized Using an Acid-Sensitive Hydrazone Linker,\u201d Cancer Research, Vol. 50, No. 20, 1990, pp. 6600-6607.","DOI":"10.1042\/bj3200293"},{"key":"ref","doi-asserted-by":"publisher","DOI":"10.1080\/10611860903012802"},{"key":"ref","doi-asserted-by":"publisher","DOI":"10.1016\/0968-0896(95)00126-2"},{"key":"ref","doi-asserted-by":"publisher","DOI":"10.1248\/cpb.45.399"},{"key":"ref","doi-asserted-by":"publisher","DOI":"10.1016\/j.jconrel.2005.10.006"},{"key":"ref","doi-asserted-by":"publisher","DOI":"10.1016\/j.bmcl.2005.07.087"},{"key":"ref","doi-asserted-by":"publisher","DOI":"10.1007\/s00262-006-0168-0"},{"key":"ref","doi-asserted-by":"crossref","unstructured":"B. K. Wong, D. Defeo-Jones, R. E. Jones, V. M. Garsky, D. M. Feng, A. Oliff, M. Chiba, J. D. Ellis and J. H. Lin, \u201cPSA-Specific and Non-PSA-Specific Conversion of a PSA-Targeted Peptide Conjugate of Doxorubicin to Its Active Metabolite,\u201d Drug Metabolism and Disposition, Vol. 29, No. 3, 2001, pp. 313-318.","DOI":"10.1042\/bj3200293"},{"key":"ref","doi-asserted-by":"publisher","DOI":"10.1007\/s10637-007-9053-8"},{"key":"ref","doi-asserted-by":"publisher","DOI":"10.1007\/s00280-009-0942-8"},{"key":"ref","doi-asserted-by":"publisher","DOI":"10.1021\/bc800117r"},{"key":"ref","doi-asserted-by":"publisher","DOI":"10.1002\/cbic.200800805"},{"key":"ref","doi-asserted-by":"publisher","DOI":"10.1042\/BA20040058"},{"key":"ref","doi-asserted-by":"crossref","unstructured":"Y. Ren, X. Zhan, D. Wei and J. Liu, \u201cIn-Vitro Reversal MDR of Human Carcinoma Cell Line by an Antisense Oligodeoxynucleotide-Doxorubicin Conjugate,\u201d Biomedicine & Pharmacotherapy, Vol. 58. No. 9, 2004, pp. 520-526.","DOI":"10.1042\/bj3200293"},{"key":"ref","doi-asserted-by":"publisher","DOI":"10.1007\/s13277-010-0019-7"},{"key":"ref","doi-asserted-by":"publisher","DOI":"10.1016\/j.biomaterials.2009.02.040"},{"key":"ref","doi-asserted-by":"crossref","unstructured":"H. Krakovicova, T. Ethch and K. Ulbrich, \u201cHPMA-Based Polymerconjugates with Drug Combinations,\u201d European Journal of Pharmacology, Vol. 37. No. 3-4, 2009, pp. 4050-4412.","DOI":"10.1042\/bj3200293"},{"key":"ref","doi-asserted-by":"publisher","DOI":"10.1016\/j.biomaterials.2008.05.016"},{"key":"ref","doi-asserted-by":"publisher","DOI":"10.1016\/S0968-0896(99)00209-6"},{"key":"ref","doi-asserted-by":"publisher","DOI":"10.1016\/j.jconrel.2008.05.010"},{"key":"ref","doi-asserted-by":"publisher","DOI":"10.1093\/jjco\/hyl004"},{"key":"ref","doi-asserted-by":"crossref","unstructured":"G. L. Griffiths, M. J. Mattes, R. Stein, S. V. Govindan, I. D. Horak, H. J. Hansen and D. M. Goldenberg, \u201cCure of SCID Mice Bearing Human B-Lymphoma Xenografts by an Anti-CD74 Antibody-Anthracycline Drug Conjugate,\u201d Clinical Cancer Research, Vol. 9, No. 17, 2003, pp. 6567-6571.","DOI":"10.1042\/bj3200293"},{"key":"ref","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-05-0204"},{"key":"ref","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.85.4.1189"},{"key":"ref","doi-asserted-by":"publisher","DOI":"10.1126\/science.8327892"},{"key":"ref","doi-asserted-by":"publisher","DOI":"10.1126\/science.3484557"},{"key":"ref","doi-asserted-by":"crossref","unstructured":"R. O. Dillman, D. E. Johnson, J. Ogden and D. Beidler, \u201cSignificance of Antigen, Drug, and Tumor Cell Targets in the Preclinical Evaluation of Doxorubicin, Daunorubicin, Methotrexate, and Mitomycin-C Monoclonal Anti-body Immunoconjugates,\u201d Molecular Biotherapy, Vol. 1, 5, 1989, pp. 250-255.","DOI":"10.1042\/bj3200293"},{"key":"ref","doi-asserted-by":"crossref","unstructured":"M. Page, D. Thibeault, C. Noel and L. Dumas, \u201cCoupling a Preactivated Daunorubicin Derivative to Antibody. A New Approach,\u201d Anticancer Research, Vol. 10, No. 2A, 1990, pp. 353-357.","DOI":"10.1042\/bj3200293"},{"key":"ref","doi-asserted-by":"publisher","DOI":"10.1016\/S0006-291X(03)00394-2"},{"key":"ref","doi-asserted-by":"crossref","unstructured":"J. R. Ogden, K. Leung, S. A. Kunda, M. W. Telander, B. P. Avner, S. K. Liao, G. B. Thurman and R. K. Oldham, \u201cImmunoconjugates of Doxorubicin and Murine Antihuman Breast Carcinoma Monoclonal Antibodies Prepared Via an N-Hydroxysuccinimide Active Ester Intermediate of Cis-Aconityl-Doxorubicin: Preparation and in Vitro Cytotoxicity,\u201d Molecular Biotherapy, Vol. 1, No. 3, 1989, pp. 170-174.","DOI":"10.1042\/bj3200293"},{"key":"ref","doi-asserted-by":"publisher","DOI":"10.1016\/j.bmc.2010.11.046"},{"key":"ref","doi-asserted-by":"publisher","DOI":"10.2165\/00003088-200544090-00005"},{"key":"ref","doi-asserted-by":"publisher","DOI":"10.1080\/15257770802145447"},{"key":"ref","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-05-1969"},{"key":"ref","doi-asserted-by":"publisher","DOI":"10.1007\/s00280-004-0949-0"},{"key":"ref","doi-asserted-by":"publisher","DOI":"10.1038\/sj.onc.1202132"},{"key":"ref","doi-asserted-by":"publisher","DOI":"10.1002\/ijc.20378"},{"key":"ref","doi-asserted-by":"crossref","unstructured":"M. Sliwkowski, X, J. A. Lofgren, G. D. Lewis, T. E. Hotaling, B. M. Fendly and J. A. Fox, \u201cNonclinical Studies Addressing the Mechanism of Action of Trastuzumab (Herceptin),\u201d Seminars in Oncology, Vol. 26, Suppl. 12, 1999, pp. 60-70.","DOI":"10.1042\/bj3200293"},{"key":"ref","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2007.12.3588"},{"key":"ref","doi-asserted-by":"crossref","unstructured":"M. A. Cobleigh, C. L. Vogel, D. Tripathy, N. J. Robert, S. Scholl, L. Fehrenbacher, J. Wolter, V. Paton, S. Shak, G. Lieberman and D. J. Slamon, \u201cMultinational Study of the Efficacy and Safety of Humanized Anti-HER2 Monoclonal Antibody in Women Who Have HER2-Overexpressing Metastatic Breast Cancer That Has Progressed after Chemotherapy for Metastatic Disease,\u201d Journal of Clinical Oncology, Vol. 17, No. 9, 1999, pp. 2639-2648.","DOI":"10.1042\/bj3200293"},{"key":"ref","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.20.3.719"},{"key":"ref","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.CAN-08-1776"},{"key":"ref","doi-asserted-by":"crossref","unstructured":"J. A. Garc\u00eda-S\u00e1enz, M. Mart\u00edn, A. Calles, C. Bueno, L. Rodr\u00edguez, J. Bobokova, A. Custodio, A. Casado and E. D\u00edaz-Rubio, \u201cBevacizumab in Combination with Metronomic Chemotherapy in Patients with Anthracycline- and Taxane-Refractory Breast Cancer,\u201d Journal of Chemotherapy, Vol. 20, No. 5, 2008, pp. 632-639.","DOI":"10.1042\/bj3200293"},{"key":"ref","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM200103153441101"},{"key":"ref","doi-asserted-by":"publisher","DOI":"10.1021\/jm9704661"},{"key":"ref","doi-asserted-by":"publisher","DOI":"10.1021\/bc980024j"},{"key":"ref","doi-asserted-by":"publisher","DOI":"10.1021\/jm950949+"},{"key":"ref","doi-asserted-by":"publisher","DOI":"10.1021\/bc00021a005"},{"key":"ref","doi-asserted-by":"publisher","DOI":"10.1002\/(SICI)1097-4636(199805)40:2<257::AID-JBM10>3.0.CO;2-J"},{"key":"ref","doi-asserted-by":"crossref","unstructured":"X. L. Wang, Y. Huang, J. Zhu, Y. B. Pan, R. He and Y. Z. Wang, \u201cChitosan-Graft Poly(p-Dioxanone) Copolymers: Preparation, Characterization, and Properties,\u201d Carbohydrate Research, Vol. 344, No. 6, 2009, pp, 801-807.","DOI":"10.1042\/bj3200293"},{"key":"ref","doi-asserted-by":"publisher","DOI":"10.1016\/j.bmcl.2005.03.046"},{"key":"ref","doi-asserted-by":"publisher","DOI":"10.1097\/01.cad.0000185182.80227.48"},{"key":"ref","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijpharm.2010.03.010"},{"key":"ref","doi-asserted-by":"publisher","DOI":"10.1007\/s002800100284"},{"key":"ref","doi-asserted-by":"publisher","DOI":"10.1021\/jm020571x"},{"key":"ref","doi-asserted-by":"publisher","DOI":"10.1021\/jo9911140"},{"key":"ref","doi-asserted-by":"crossref","unstructured":"P. A. Trail, D. Willner, J. Knipe, A. J. Henderson, S. J. Lasch, M. E. Zoeckler, M. D. TrailSmith, T. W. Doyle, H. D. King, A. M. Casazza, J. Brown, S. J. Hofstead, R. S. Greenfield, R. A. Firestone, K. Mosure, K. F. Kadow, M. B. Yang, K. E. Hellstrom and I. Hellstrom, \u201cEffect of linker Variation on the Stability, Potency and Efficacy of Carcinoma-Reactive BR64-Doxorubicin Immunoconjugates,\u201d Cancer Research, Vol. 57, No. 1, 1997, pp. 100-105.","DOI":"10.1042\/bj3200293"},{"key":"ref","doi-asserted-by":"publisher","DOI":"10.1016\/j.jconrel.2007.06.007"},{"key":"ref","doi-asserted-by":"publisher","DOI":"10.1016\/0021-9673(95)01054-8"},{"key":"ref","doi-asserted-by":"publisher","DOI":"10.1177\/0960327107073825"},{"key":"ref","doi-asserted-by":"crossref","unstructured":"D. Lebrecht, A. Geist, U. P. Ketelsen, J. Haberstroh, B. Setzer, F. Kratz and U. Walker, \u201cThe 6-Maleimidocaproyl Hydrazone Derivative of Doxorubicin (Doxoemch) Is Superior to Free Doxorubicin with Respect to Cardiotoxicity and Mitochondrial Damage,\u201d International Journal of Cancer, Vol. 120, No. 4, 2006, pp. 927-934.","DOI":"10.1042\/bj3200293"},{"key":"ref","doi-asserted-by":"publisher","DOI":"10.1248\/bpb.21.56"},{"key":"ref","doi-asserted-by":"publisher","DOI":"10.1021\/js970246a"},{"key":"ref","doi-asserted-by":"publisher","DOI":"10.1016\/j.jchromb.2006.03.023"},{"key":"ref","doi-asserted-by":"publisher","DOI":"10.1016\/0378-4347(96)00048-5"},{"key":"ref","doi-asserted-by":"publisher","DOI":"10.4236\/jct.2011.21004"},{"key":"ref","doi-asserted-by":"publisher","DOI":"10.1089\/cbr.2011.1097"},{"key":"ref","doi-asserted-by":"publisher","DOI":"10.1023\/A:1011018525121"},{"key":"ref","doi-asserted-by":"publisher","DOI":"10.1159\/000217705"},{"key":"ref","doi-asserted-by":"crossref","unstructured":"G. P. Sivam, P. J. Martin, R. A. Reisfeld and B. M. Mueller, \u201cTherapeutic Efficacy of a Doxorubicin Immunoconjugate in a Preclinical Model of Spontaneous Metastatic Human Melanoma,\u201d Cancer Research, Vol. 55, No. 11, 1995, pp. 2352-2356.","DOI":"10.1042\/bj3200293"},{"key":"ref","doi-asserted-by":"publisher","DOI":"10.2174\/1381612053507602"},{"key":"ref","doi-asserted-by":"publisher","DOI":"10.1016\/j.bmcl.2009.06.056"},{"key":"ref","doi-asserted-by":"publisher","DOI":"10.1021\/mp060059y"},{"key":"ref","doi-asserted-by":"publisher","DOI":"10.1016\/j.jconrel.2007.08.018"},{"key":"ref","doi-asserted-by":"publisher","DOI":"10.1002\/cncr.24798"},{"key":"ref","doi-asserted-by":"publisher","DOI":"10.1021\/bc970102n"},{"key":"ref","doi-asserted-by":"publisher","DOI":"10.1016\/0968-0896(95)00125-Z"},{"key":"ref","doi-asserted-by":"crossref","unstructured":"A. K. Fry, K. F. Schilke, J. McGuire and K. E. Bird, \u201cSynthesis and Anticoagulant Activity of Heparin Immobilized \u2018End-On\u2019 to Polystyrene Microspheres Coated with End-Group Activated Polyethylene Oxide,\u201d Journal of Biomedical Materials Research Part B: Applied Biomaterials, Vol. 94, No. 1, 2010, pp. 187-195.","DOI":"10.1042\/bj3200293"},{"key":"ref","doi-asserted-by":"publisher","DOI":"10.1023\/A:1016010524510"},{"key":"ref","doi-asserted-by":"publisher","DOI":"10.1016\/0022-1759(81)90213-1"},{"key":"ref","doi-asserted-by":"publisher","DOI":"10.1038\/nprot.2007.144"},{"key":"ref","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijbiomac.2010.05.015"},{"key":"ref","doi-asserted-by":"publisher","DOI":"10.1023\/A:1023454107190"},{"key":"ref","doi-asserted-by":"publisher","DOI":"10.1016\/j.actbio.2009.12.024"},{"key":"ref","doi-asserted-by":"publisher","DOI":"10.1039\/c0ob00355g"},{"key":"ref","doi-asserted-by":"publisher","DOI":"10.1080\/10611860290007568"},{"key":"ref","doi-asserted-by":"crossref","unstructured":"American Cancer Society, \u201cCancer Facts and Figures 2004,\u201d American Cancer Society, 2004, pp. 1-60.","DOI":"10.1042\/bj3200293"},{"key":"ref","doi-asserted-by":"publisher","DOI":"10.1093\/jnci\/80.14.1154"},{"key":"ref","doi-asserted-by":"publisher","DOI":"10.1080\/1061186021000038058"},{"key":"ref","doi-asserted-by":"publisher","DOI":"10.1038\/sj.bjc.6604528"},{"key":"ref","doi-asserted-by":"publisher","DOI":"10.1016\/S0169-5002(03)00273-3"},{"key":"ref","doi-asserted-by":"publisher","DOI":"10.1007\/s00280-005-0005-8"},{"key":"ref","doi-asserted-by":"publisher","DOI":"10.1016\/0145-2126(95)00106-9"},{"key":"ref","doi-asserted-by":"publisher","DOI":"10.1177\/1087057104265386"},{"key":"ref","doi-asserted-by":"publisher","DOI":"10.1016\/j.tiv.2007.08.006"},{"key":"ref","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejmech.2007.09.003"},{"key":"ref","doi-asserted-by":"publisher","DOI":"10.1159\/000140462"},{"key":"ref","doi-asserted-by":"publisher","DOI":"10.1021\/nl071521o"},{"key":"ref","doi-asserted-by":"publisher","DOI":"10.1186\/1477-7827-5-38"},{"key":"ref","doi-asserted-by":"publisher","DOI":"10.1186\/1476-4598-5-34"},{"key":"ref","doi-asserted-by":"publisher","DOI":"10.1021\/mp100235w"},{"key":"ref","doi-asserted-by":"publisher","DOI":"10.1016\/0006-291X(81)91644-2"},{"key":"ref","doi-asserted-by":"crossref","unstructured":"Y. Zhang, N. Wang, N. Li, T. Liu and Z. Dong, \u201cThe Antitumor Effect of Adriamycin Conjugated with Monoclonal Antibody against Gastric Cancer In-Vitro and In-Vivo,\u201d Acta Pharmaceutica Sinica, Vol. 27, No. 5, 1992, pp. 325-330.","DOI":"10.1042\/bj3200293"},{"key":"ref","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.86.10.3778"},{"key":"ref","doi-asserted-by":"publisher","DOI":"10.1007\/BF02678542"},{"key":"ref","doi-asserted-by":"crossref","unstructured":"M. D. Pegram, A. Lopez, G. Konecny and D. J. Slamon, \u201cTrastuzumab and Chemotherapeutics: Drug Interactions and Synergies,\u201d Seminars in Oncology, No. 27, Suppl. 11, 2000, pp. 21-25.","DOI":"10.1042\/bj3200293"},{"key":"ref","doi-asserted-by":"publisher","DOI":"10.1053\/sonc.2001.22812"},{"key":"ref","doi-asserted-by":"publisher","DOI":"10.1159\/000055402"},{"key":"ref","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-05-1325"},{"key":"ref","doi-asserted-by":"crossref","unstructured":"M. Landriscina, F. Maddalena, A. Fabiano, A. Piscazzi, O. La Macchia and M. Cignarelli, \u201cErlotinib Enhances the Proapoptotic Activity of Cytotoxic Agents and Synergizes with Paclitaxel in Poorly-Differentiated Thyroid Carcinoma Cells,\u201d Anticancer Research, Vol. 30, No. 2, 2010, pp. 473-480.","DOI":"10.1042\/bj3200293"},{"key":"ref","doi-asserted-by":"crossref","unstructured":"F. Ciardiello, R. Bianco, V. Damiano, S. De Lorenzo, S. Pepe, S. De Placido, Z. Fan, J. Mendelsohn, A. Bianco and G. Tortora, \u201cAntitumor Activity of Sequential Treatment with Topotecan and Anti-Epidermal Growth Factor Receptor Monoclonal Antibody C225,\u201d Clinical Cancer Research, Vol. 5, No. 4, 1999, pp. 909-916.","DOI":"10.1042\/bj3200293"},{"key":"ref","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2407-10-397"},{"key":"ref","doi-asserted-by":"crossref","unstructured":"L. Zhang, D. Yu, D. J. Hicklin, J. A. Hannay, L. M. Ellis and R. E. Pollock, \u201cCombined Anti-Fetal Liver Kinase 1 Monoclonal Antibody (Anti-VEGFR) and Continuous Low-Dose Doxorubicin Inhibits Angiogenesis and Growth of Human Soft Tissue Sarcoma Xenografts by Induction of Endothelial Cell Apoptosis\u201d Cancer Research, Vol. 62, No. 7, 2002, pp. 2034-2042.","DOI":"10.1042\/bj3200293"},{"key":"ref","doi-asserted-by":"publisher","DOI":"10.1007\/BF01526203"},{"key":"ref","doi-asserted-by":"crossref","unstructured":"H. J. Hansen, G. L. Ong and H. Diril, \u201cInternalization and Catabolism of Radiolabeled Antibodies to the MHC Class-II Invariant Chain by B-Cell Lymphomas,\u201d Bio- chemical Journal, Vol. 320, 1996, pp. 293-300.","DOI":"10.1042\/bj3200293"},{"key":"ref","doi-asserted-by":"crossref","unstructured":"A. C. Stan, D. L. Radu, S. Casares, C. A. Bona, T. D. Brumeanu, \u201cAntineoplastic Efficacy of Doxorubicin Enzymatically Assembled on Galactose Residues of a Monoclonal Antibody Specific for the Carcinoembryonic Antigen,\u201d Cancer Research, Vol. 59, No. 1, 1999, pp. 115-121.","DOI":"10.1042\/bj3200293"},{"key":"ref","doi-asserted-by":"crossref","unstructured":"M. Pimm, V, M. A. Paul, T. Ogumuyiwa and R. W. Baldwin, \u201cBiodistribution and Tumour Localization of a Daunomycin-Monoclonal Antibody Conjugate in Nude Mice and Human Tumour Xenografts,\u201d Cancer Immunology, Immunotherapy, Vol. 27, No. 3, 1988, pp. 267-271.","DOI":"10.1042\/bj3200293"}],"container-title":["Journal of Cancer Therapy"],"original-title":[],"link":[{"URL":"http:\/\/www.scirp.org\/journal\/PaperDownload.aspx?DOI=10.4236\/jct.2012.325089","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.scirp.org\/journal\/doi.aspx?DOI=10.4236\/jct.2012.325089","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.scirp.org\/journal\/doi.aspx?DOI=10.4236\/jct.2012.325089","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2017,7,7]],"date-time":"2017-07-07T05:23:46Z","timestamp":1499405026000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.scirp.org\/journal\/doi.aspx?DOI=10.4236\/jct.2012.325089"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012]]},"references-count":122,"journal-issue":{"issue":"05","published-print":{"date-parts":[[2012]]}},"URL":"https:\/\/doi.org\/10.4236\/jct.2012.325089","relation":{},"ISSN":["2151-1934","2151-1942"],"issn-type":[{"value":"2151-1934","type":"print"},{"value":"2151-1942","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012]]}}}